Diabetes research

While diabetes is a problem that affects such a vast cross-section of the population, surprisingly little is known about the disease. There are many organizations that are trying to pinpoint exactly what causes diabetes and how to stop it before it starts, but there is still much work to be done. Organizations such as the Diabetes Action Research and Education Foundation, or DAREF, the Juvenile Diabetes Research Foundation, the Diabetes Research Institute and the Diabetes Research and Wellness Foundation are some of the more prominent institutions that are attempting to learn more about this chronic illness.

The currently undertaken projects by these organizations focus on a wide range of research. Subjects covered by these foundations include immunotherapy for Type I diabetes, the impacts of exercise training for those with diabetes, arterial issues, enhancing the cell survival of important agents in diabetes, the use of gene therapy to treat diabetes, and many others. Research into a Type I diabetes medication that helps the beta cells in the pancreas to live longer is currently underway by the Diabetes Action Research and Education Foundation that may prove to help patients create insulin on their own, helping to reduce the dependence on outside sources of insulin. This study shows promise in that 8 of 10 patients studied experienced an increase in C-peptide levels, a precursor to fixing the problem. This study is still in phase 2, and if it is completed successfully then a phase 3 study could potentially offer a non-toxic and effective therapy for juveniles that are at risk of developing Type I diabetes. DAREF is a leading member in the fight to cure diabetes, and donations can be given at http://www.diabetesaction.org. Your money will be going to an honest research team that meets the guidelines of the Better Business Bureau Wise Giving Alliance’s Standards for Charity Accountability, ensuring that your donation is not being abused.

Another research that is being undertaken is the study of the use of cinnamon to lower blood sugar levels. This study was also funded by DAREF and the research for the project was conducted by Dr. Richard Anderson at the United States Department of Agriculture’s Human Nutrition Resource Center. Anderson was able to effectively isolate the compound in cinnamon which causes lowered blood sugar. In addition to the compound’s efficacy in helping maintain blood sugar levels, it was also found to reduce total cholesterol levels by as much as 26 percent. Low density lipoproteins, or LDLs, are known as the “bad” type of cholesterol. Levels of LDL were decreased by 10 to 24 percent by cinnamon. In addition, triglyceride levels were decreased 23 to 30 percent.

The reason that cinnamon is so helpful to someone with diabetes is the way that it inhibits enzymes in the body that may be responsible to insulin resistance. This is especially noteworthy to those who are afflicted with Type II diabetes and have insulin resistance problems. Cinnamon also was shown to increase the body’s sensitivity to insulin causing insulin to be used more efficiently. The isolated compounds causing these effects are known as Type-A polymers. After isolation, this product became available on the market under the brand name Cinnulin PF. This just goes to show that funding can lead to research which can be beneficial to those with diabetes. If you or someone you know is afflicted with this chronic illness, funding a research team can be beneficial to you as well as the millions of other diabetes sufferers in the world.